Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Therapy
New HIV/AIDS therapy data have been reported by C. Payan and co-authors
August 6th, 2007
Scientists discuss in "Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients" new findings in HIV/AIDS. According to a study from Brest, France, "An algorithm based on a 2 log(10) decline in hepatitis C virus (HCV) RNA at week (W) 12 has been proposed in US and European recommendations for the management of patients with chronic hepatitis C treated with pegylated-interferon and ribavirin. We examined rapid virological response (RVR; at W2 and W4 after the initiation of therapy) in HIV/HCV co-infected patients." "Using HCV RNA measurements (Versant HCV RNA 3.0, Cobas...
Source: Hepatitis Weekly (2007-08-06)
|
